The research arm at Pacific Neuroscience Institute confronts some of medicine’s biggest brain tumor challenges. Read this story about glioblastoma and the innovative clinical trial treatment a patient received.
Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.
Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke and other neurological areas. Call our center at 310-829-8265 to enroll.
Check out Pacific Neuroscience Institute’s advanced clinical trials line up for May 2018. PNI is very excited to announce a new clinical trial for the assessment and treatment of patients with newly diagnosed glioblastoma. Find out how Dr. Santosh Kesari’s protocol tackles brain cancer treatment in a whole new way.
Pacific Neuroscience Institute is pleased to announce a new clinical trial for traumatic brain injury patients who have been suffering from chronic motor deficits for more than a year. This study is currently enrolling patients. Clinical trials help bring much needed treatments and therapies to market. Find out more about PNI trials for treatment of primary brain tumors such as glioblastoma, metastatic brain tumors that arise from cancers affecting the breast, lung or skin, quality and outcomes research and other neurological studies.
The ever-expanding scope of medicine has radically transformed our lives. Now that we are living longer, how do we deal with diseases that come along with aging? Read about cancer survivorship strategies and how to thrive.
Neurosciences and Neurotherapeutics Brain-based disorders are among the most challenging conditions to treat. However, the neurosciences faculty at Pacific Neuroscience Institute and the John Wayne[ Read More ]
We are pleased to announce a new clinical trial using the Optune device. Ongoing trials in stroke, quality & outcomes research & brain cancer are actively recruiting. Read more.
We are pleased to present our new clinical trials this month. Find out about our studies in stroke and quality & outcomes research as well as brain cancer.